In 1976, GEICO’s stock fell from $61 to $2 a share. Management had mispriced risk so badly that the company nearly ran out of capital. Most investors looked at that chart and saw a business in terminal decline. Warren Buffett looked at the same company and saw something else: a direct-to-consumer distribution model that remained, structurally, the lowest-cost way to sell auto insurance in America, sitting underneath a balance sheet that had run out of room.
That distinction sounds obvious once someone points it out. It is one of the harder calls to make in real time, and it is the single most important judgment a distressed credit investor makes before committing capital to a name.
Picture two mid-sized industrial companies filing Chapter 11 in the same quarter, carrying similar leverage, and showing revenue declines of roughly the same size. On a term sheet, they look identical. What separates them sits outside the term sheet entirely.
One company borrowed to fund an acquisition that never delivered the cost savings it was underwritten to produce, and the acquired business has been quietly losing customers to a competitor for two years. The other company has a durable base of repeat customers and a defensible market position, but it was recapitalized by a sponsor near the top of a cycle, at a multiple and a leverage level the business could never have carried through a downturn.
The first company’s franchise is deteriorating. The second company’s franchise is intact. The capital structure failed in both cases. Only one of these businesses is actually losing what makes it valuable, and treating the two the same is one of the more expensive mistakes a credit investor can make in distress.
The market’s default read is simple: debt trading at 40 cents on the dollar means the business is failing. Sometimes that’s correct. Often it is an incomplete picture, and generalizing from a distressed price to a distressed business is exactly where opportunity gets missed.
What usually happened is more specific than a failing business. Too much debt got issued at the peak of a cycle, at multiples and rates that no longer reflect where credit markets sit today. In the right businesses, the brand, the customer relationships, and the operational infrastructure survive intact, buried beneath a balance sheet that no longer fits the business underneath it.
Well-documented examples like GEICO or Chrysler are useful because the record is public, but the middle market is where this distinction gets missed most often, precisely because the nucleus rarely looks like a recognizable brand. A specialty distributor doesn’t have a household name. A regulated service provider doesn’t have a patent portfolio. What they often have instead is a proprietary ordering system, a multi-year supply agreement, or a licensing requirement that makes switching to a competitor slow and expensive.
None of that shows up on a term sheet. It shows up in the customer contracts, and reading those contracts takes time that a forced seller usually doesn’t have. A CLO manager facing an overcollateralization test, or a bank clearing a position to protect its capital ratios, is working against a clock measured in days. Reading the agreements underneath a downgraded credit takes weeks. The selling happens on the number that’s visible: revenue is down, therefore the credit is bad. The nucleus, if one exists, lives in the numbers that aren’t visible from a P&L.
That gap between what’s visible and what’s actually true is where mispricing comes from. It’s also where the risk comes from if the call is wrong. Identifying a nucleus that turns out not to exist, because the competitive advantage was already eroding before the balance sheet cracked, is the costlier version of this mistake. The inverse question matters just as much as the first: is the core of this business genuinely intact, or did what looked like a moat quietly disappear before the debt ever traded down?
This is why underwriting time gets spent reading contracts, supplier agreements, and customer concentration data rather than modeling recovery scenarios off a capital structure alone. A recovery model tells an investor what the debt is worth if the business survives in its current form. It says nothing about whether the business should survive in that form, or what it’s worth once the balance sheet gets fixed.
The businesses worth owning through a restructuring are the ones where the nucleus survives the process largely intact and mainly needs a cleaner balance sheet, and in most cases, new leadership, to translate that surviving advantage back into a durable company. The businesses to avoid are the ones where the debt is cheap for a reason that has nothing to do with a cycle and everything to do with a business that was already losing what made it valuable long before the capital structure ever failed.
This discipline tends to matter most exactly when it’s hardest to apply, and that’s roughly where credit markets sit today. A record wave of liability management exercises worked through the traded loan and bond markets in 2024 and 2025 as private equity sponsors bought time on debt issued at peak multiples and trough rates. Attention is now shifting to a harder question: whether the earnings underneath those debt loads can actually support them. A growing share of the syndicated loan market is trading at distressed levels, direct lending flows have reversed, and existing portfolios are coming to market to meet redemptions.
None of that tells an investor which of those businesses still have a nucleus worth owning. It only tells you that more names are about to get the chance to prove it. A slower, longer credit cycle produces more of exactly the situation described above: companies where the capital structure failed for cyclical reasons, sitting next to companies where the capital structure failed because the business underneath it was already coming apart. The volume of distress creates more opportunities to make this call well. It also creates more opportunities to make it badly, at scale, if the underwriting shortcuts the contract-level work in favor of a faster read on the headline number.
This material is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities or investment advisory services. The views expressed herein are those of Axar Capital as of the date of publication and are subject to change without notice.
This material is not intended to provide, and should not be relied upon for, investment, legal, or tax advice. Any forward-looking statements or discussions of potential outcomes are based on current expectations and assumptions and are subject to change. There can be no assurance that any investment strategy will be successful or that any outcomes discussed herein will be achieved. References to specific investments are provided for illustrative purposes only and do not represent all investments made by Axar Capital. Past performance is not indicative of future results.
This content is provided for informational and educational purposes only and does not constitute investment advice or a solicitation to invest. All investments involve risk, including potential loss of principal. Historical examples referenced herein are provided for illustrative purposes only and do not represent investments made, managed, or recommended by Axar Capital unless expressly stated otherwise. Past performance is not indicative of future results. The views expressed reflect the current opinions of Axar Capital Management LP, which may change without notice.
How do you determine whether a company’s core business survived a bankruptcy filing, rather than assuming it based on brand recognition alone?
We look for evidence in customer contracts, competitive positioning, and unit economics rather than relying on reputation or management’s own account. A durable advantage that can’t be traced to a specific structural mechanism, a contract term, a license, a cost position, isn’t one we’ll underwrite as real.
What’s the difference between a company that’s cheap because the market panicked and one that’s cheap because it’s actually failing?
The first has a capital structure that no longer fits an otherwise sound business; the debt trades at a discount because forced sellers need liquidity, not because the franchise is deteriorating. The second is losing the thing that made it valuable, independent of what’s happening to its balance sheet.
Why do forced sellers create these mispricing opportunities more often than willing ones do?
CLOs facing overcollateralization tests, banks preserving capital ratios, and mandate-constrained funds that cannot hold defaulted paper are all selling on a timeline set by their own constraints, not by the company’s actual prospects. That gap between institutional pressure and intrinsic value is where the entry price comes from.
Does identifying a durable nucleus change how an investment gets approached after the initial underwrite?
Yes. It shapes decisions about board involvement, management change, and how much capital gets committed as a position develops, since the thesis depends on translating a surviving competitive advantage into a company that can operate without the distress that got it there.
Are there situations where a business looks like it has a durable nucleus but doesn’t?
Yes, most often when the competitive advantage was already eroding before the balance sheet failed. A brand can lose relevance. A distribution edge can be replicated by a competitor. Separating genuine durability from a market that simply hasn’t noticed the erosion yet is the harder, and more important, half of the work.
Axar Capital Management LP is a $3.3 billion opportunistic investment manager focused on U.S. middle market companies with $200 million to $800 million in debt outstanding. Founded in 2015 and 100% employee-owned, Axar specializes in complex situations where traditional institutional capital operates inefficiently. The firm is headquartered at 402 W 13th Street, New York, NY.
Disclaimer: Axar Capital Management LP (“Axar”) has prepared this content for informational purposes only. This content is not intended to constitute legal, tax, financial, or investment advice. While all information contained herein is believed to be accurate, no guarantee, representation or warranty is made as to its accuracy, completeness or fairness. Certain information reflects the current opinions of Axar which may prove to be incorrect and are subject to change. Past performance is not indicative of future results. Investing involves a material risk of loss. Certain statements herein reflect forward-looking views, which are inherently uncertain and subject to change. Actual results may differ materially.